Tasigna
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
These medication errors have occurred in health care facilities at least once. They will happen again—perhaps where you work…
1. Pinilla-Ibarz J., et al. The expanding options for front-line treatment in patients with newly diagnosed CML, Critical Reviews…
A simple and practical synthetic approach for tasigna was described here in six steps with high yield (40%). All of the…
FDA has approved a label update for nilotinib (Tasigna, Novartis). The approval includes data from a 24-month analysis of the…
Development of a fluorescent analog of BCR-ABL kinase inhibitor, Tasigna® (AMN-107, nilotinib) to study its interaction with ABC…